It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
11
Rapid Review
Table
4
Research Team
Apply
EOC
3
Epidemiology & Modelling
3
Laboratory
5
Personal Protective Equipment
1
Status
Apply
5. Updated review
5
3. Completed
7
Category
Apply
Clinical Management
1
Clinical Presentation
Diagnostics
1
Epidemiology
7
Healthcare Services
4
Infection Prevention and Control
2
Subject
Apply
Antibodies
4
Asymptomatic
2
Cancer
1
Chemotherapy
1
Clinical Presentation
4
Comorbidities
2
Critical Care
2
Elderly
1
Health Planning
2
Hospitalization
1
Immunity
4
Infection Prevention and Control
2
More
Population
Apply
All
8
Clinical Setting
Apply
Ambulatory
3
Community
2
Emergency
1
ICU
2
Long Term Care
3
Medicine Unit
2
Primary care
3
Public Health
2
Advanced Search
All Records
Rapid Review
Long Covid
Natural History
Clinical Presentation
Sorted by
Newest
Sort by Relevance
Sort by Research Question / Title
Sort by Oldest
Table View
List View
Citation View
Expand all
Collapse all
Select All
12 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
June 20, 2022
What are long COVID's demands on the healthcare system, and its severity of the illness?
EPM210602v002 RR
Epidemiology & Modelling
March 31, 2022
What is the incidence and duration of long COVID cases?
EPM210601v2 RR
Epidemiology & Modelling
October 29, 2021
Long COVID: What does it mean for the healthcare system and programs to deal with it?
EOC021901v2 RR
EOC
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR
EOC
October 13, 2020
What is the post acute covid syndrome and its implications in terms of health services?
EOC091601 RR
EOC
June 3, 2020
What proportion of disease transmission is due to persons who are asymptomatic over the entire course of illness?
EPM051301 RR
Epidemiology & Modelling
May 19, 2020
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
LAB041601v2 RR
Laboratory
May 8, 2020
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
LAB040701v2 RR
Laboratory
April 17, 2020
What distinguishes COVID-19 from influenza-like illnesses?
PPE041701 RR
Personal Protective Equipment
April 17, 2020
How well does the presence and level of antibodies predict the clinical course of disease?
LAB041501 RR
Laboratory
April 15, 2020
At what time in the disease timeline of COVID-19 do antibodies develop?
LAB041402 RR
Laboratory
April 11, 2020
Is the IgM or IgG immune response protective?
LAB040803 RR
Laboratory
12 records – page 1 of 1.
Prev
Next